SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001171843-21-008004
Filing Date
2021-11-16
Accepted
2021-11-16 16:16:51
Documents
1
Period of Report
2021-11-12

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4190
  Complete submission text file 0001171843-21-008004.txt   5574
Mailing Address C/O REV GROUP, INC. 111 EAST KILBOURN AVENUE, SUITE 2600 MILWAUKEE WI 53202
Business Address
Canan John (Reporting) CIK: 0001374366 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35776 | Film No.: 211416321

Mailing Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5
Business Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5 450-686-4555
Acasti Pharma Inc. (Issuer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations